Safety evaluation of Shwasakuthara Rasa (herbo-mineral Ayurvedic formulation): A 90-day repeated-dose oral toxicity study in Wistar albino rats
Journal of Drug Research in Ayurvedic Sciences · 2026-09 · 11 (5) · 342-351
DOI: 10.4103/jdras.jdras_321_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Drug Research in Ayurvedic Sciences, online erschienen am 29.10.2026. Verfasst von Deeksha Kango und 4 weiteren Autor:innen. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Shwasakuthara Rasa (SKR), a traditional Ayurvedic herbo-mineral formulation, incorporates heavy metals, minerals, and herbal drugs, including Parada (Mercury), Manahshila (Realgar), and Vatsanabha ( Aconitum chasmanthum Stapf ex Holmes). Despite their extensive historical use and perceived safety, concerns regarding the heavy metal content of such formulations have necessitated an investigation into their safety profile. METHODS: A repeated-dose 90-day oral toxicity study of SKR was performed in Wistar albino rats to evaluate its subchronic toxicity profile. Animals were administered daily oral doses corresponding to the therapeutic equivalent dose (TED; 22.5 mg/kg), TED×5 (112.5 mg/kg), and TED×10 (225 mg/kg), with an additional TED×10 recovery group. The formulation was administered with honey as an adjuvant for 90 days, followed by a 30-day recovery period. Subsequently, the hematological, biochemical, and histopathological parameters were evaluated. RESULTS: Administration of SKR did not cause significant changes in the hematological or serum biochemical parameters across all doses. Histopathological analysis revealed minor hepatic alterations, including unifocal necrosis and fatty degeneration in one rat treated with the highest dose. However, rats in the recovery group showed normal liver architecture, indicating that the observed changes were reversible. These findings suggest that SKR, when prepared and administered following traditional Ayurvedic guidelines, does not exhibit significant toxicity, even at elevated doses and with repeated administration. The reversible nature of the hepatic changes supports its safety profile, highlighting SKR’s suitability for clinical use without causing systemic toxicity. CONCLUSION: Repeated oral administration of SKR for 90 days did not elicit significant treatment-related toxicological effects in Wistar rats, establishing a no-observed-adverse-effect level (NOAEL) of 225 mg/kg (p.o.). These findings support its favorable preclinical safety profile and provide a translational framework for future clinical studies assessing its therapeutic potential and long-term safety.
Zitieren
APA
Kango, D., Parekh, D. N., Chaudhari, S., Nariya, M., & Patgiri, B. (2026). Safety evaluation of Shwasakuthara Rasa (herbo-mineral Ayurvedic formulation): A 90-day repeated-dose oral toxicity study in Wistar albino rats. Journal of Drug Research in Ayurvedic Sciences, 11(5), 342-351. https://doi.org/10.4103/jdras.jdras_321_25
Vancouver
Kango D, Parekh DN, Chaudhari S, Nariya M, Patgiri B. Safety evaluation of Shwasakuthara Rasa (herbo-mineral Ayurvedic formulation): A 90-day repeated-dose oral toxicity study in Wistar albino rats. Journal of Drug Research in Ayurvedic Sciences. 2026;11(5):342-351. doi:10.4103/jdras.jdras_321_25
BibTeX
@article{Kango2026,
author = {Kango, Deeksha and Parekh, Dipali N. and Chaudhari, Swapnil and Nariya, Mukesh and Patgiri, Biswajyoti},
title = {Safety evaluation of Shwasakuthara Rasa (herbo-mineral Ayurvedic formulation): A 90-day repeated-dose oral toxicity study in Wistar albino rats},
journal = {Journal of Drug Research in Ayurvedic Sciences},
year = {2026},
volume = {11},
number = {5},
pages = {342--351},
doi = {10.4103/jdras.jdras_321_25}
}
EUVIMED